As Medicaid enrollment grows under the program's expansion, there are not enough providers to serve the increased amounts of enrollees, according to a new report from the Office of the Inspector General that measured the availability of specific providers in Medicaid managed care networks.
As Medicaid enrollment grows under expansion of the program due to the Affordable Care Act, there are not enough providers to serve the increased amounts of enrollees, according to a new report from the Office of the Inspector General (OIG) that measured the availability of specific providers in Medicaid managed care networks.
Half of providers in the sample of 1800 primary care providers and specialists assessed could not offer appointments to Medicaid enrollees. More than a third (35%) could not even be found at the location listed by the plan.
“When providers listed as participating in a plan cannot offer appointments, it may create a significant obstacle for an enrollee seeking care,” according to the report. “Moreover, it raises questions about the adequacy of provider networks—it suggests that the actual size of provider networks may be considerably smaller than what is presented by Medicaid managed care plans.”
Another 8% were at the location listed, they said they were not participating in the plan. In some cases they had participated in the past, but in others the providers had never participated in the Medicaid managed care plan, according to the report. Lastly, another 8% said they were not accepting new patients.
Of those providers who were offering appointments to Medicaid patients, the wait time was roughly 2 weeks, although 10% had wait times longer than 2 months. Although specialists tended to have longer wait times, primary care providers were less likely to offer appointments, according to the findings.
Based on the report, OIG recommends that CMS work with states in order to: assess the number of network providers who can offer timely appointments; improve the accuracy of plan information; ensure plans’ networks are adequate and meet the needs of enrollees; and ensure plans are complying with existing state standards and assess whether additional standards are needed.
“Our findings demonstrate significant vulnerabilities in provider availability, which is a key indicator for access to care,” the report concludes. “These findings also raise serious questions about the abilities of plans, states, and CMS to ensure that access-to-care standards are met.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More